NYU Langone launches new center to advance scientific discovery and treatment of neurodegenerative diseases

NYU Langone Health announced today the launch of the Parekh Center for Interdisciplinary Neurology, made possible by a gift provided by Deven and Monika Parekh through the Psquared Charitable Foundation. The center helps bridge neuroscientific knowledge across the institution to advance scientific discovery and treatment of neurodegenerative conditions such as multiple sclerosis, Parkinson's disease, epilepsy,

Bioinformation tool improves the precision of personalized nutrition

Researchers at the Genomics and Health Department at the Foundation for the Promotion of Health and Biomedical Research of Valencia Region—FISABIO) have published an article in Nature Communications presenting the bioinformation tool AGREDA, a system for developing personalized nutrition programs that accounts for the composition of each individual’s microbiota. The study included the participation of

Stem cells and their role in lung transplant rejection

A lung transplant can mean the difference between life and death for people with diseases such as pulmonary fibrosis, chronic obstructive pulmonary disease (COPD) and even severe COVID-19. Yet, recipients of donor lungs must take daily medications to stave off damage caused by their own immune system, which attacks the organs it recognizes as foreign—a

Updated MS Guidelines Advocate Earlier, More Aggressive Treatment

Updated European guidelines on the treatment of patients with multiple sclerosis (MS) have been announced, and include a recommendation for siponimod (Mayzent) in progressive MS, as well as a general emphasis toward earlier and more aggressive treatment. The updated guidelines were presented at last week’s European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS)

Lewy body dementia exacerbated by immune response

T-cells respond to buildups of alpha-synuclein, the aggregated protein clumps that are a feature of neurodegenerative diseases including dementia with Lewy bodies and Parkinson’s disease (PD), according to a Northwestern Medicine study published in Science. This autoimmune response proves harmful, and inhibiting signaling pathways that trigger the response may represent a future therapeutic target, according

More than 140K US kids lost caregivers to COVID-19

COVID’s devastating toll on kids’ mental health not over yet Children’s Hospital Colorado declares a mental health state of emergency; Fox News correspondent Aishah Hasnie reports on the startling statistics. More than 140,000 U.S. children lost a parent, grandparent or other caregiver to COVID-19, a study found, with researchers noting significant racial and ethnic disparities

Newborns impacted by moms’ lack of health literacy

Healthy mom, healthy baby. The concept sounds simple enough, but a recent Northwestern Medicine study found the level of health literacy—how someone obtains, uses and understands health information—among pregnant people isn’t where it needs to be, and it’s having a negative impact on babies in utero and after birth, especially among people of color. Of

Failure to Communicate Doc-to-Doc Blamed for Patients Death

The family of a man who died from a rare and feared complication of head and neck cancer has filed a $34 million lawsuit against the medical center where he was treated, alleging that his death would have been avoided had there been better communication between the surgical oncologist and the treatment team. The patient

UK govt under spotlight as COVID cases rise again

Britain has repeatedly trumpeted its mass vaccination programme against COVID-19, hailing its early approval of jabs as a key part of the long struggle to return to normal life. But infection rates remain stubbornly high, contrasting sharply with its European neighbours and prompting fresh questions of the government. For two weeks, the number of new

Hybrid closed-loop therapy beneficial for children with type 1 diabetes

(HealthDay)—For children and adolescents with type 1 diabetes, hybrid closed-loop (HCL) therapy improves glycemic control and quality of life, according to a study published online Oct. 11 in JAMA Pediatrics. Mary B. Abraham, Ph.D., from the University of Western Australia, and colleagues examined the percentage of time spent in the target glucose range using HCL